Contact

Our portfolio

TrianecT

TrianecT develops StrokePointer, a portable EEG device that detects stroke severity in ambulances. The technology combines brain activity measurement through a proprietary headset with AI to diagnose Large Vessel Occlusion (LVO) strokes. Detection of an LVO stroke in the ambulance will allow patients to be immediately transported to a stroke center for timely treatment, to drastically improve the patient outcomes.

  • Institute: Amsterdam UMC
Industry: Diagnostics, Medical Technology, Stroke
  • Founding year: 2022
Visit website

Want to get in contact about TrianecT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Fermioniq
Combining quantum computing and classical simulations for material science.
SolarFoil
Enhancing plant growth with solar-powered nanotechnology.
InspectT
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Fermioniq
Combining quantum computing and classical simulations for material science.
SolarFoil
Enhancing plant growth with solar-powered nanotechnology.
InspectT
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Explore full AAV portfolio
Contact